Dolby Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Dolby Laboratories has a total shareholder equity of $2.4B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.9B and $573.2M respectively. Dolby Laboratories's EBIT is $241.3M making its interest coverage ratio -7.4. It has cash and short-term investments of $797.6M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -7.4x |
Cash | US$797.64m |
Equity | US$2.36b |
Total liabilities | US$573.22m |
Total assets | US$2.94b |
Recent financial health updates
No updates
Recent updates
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Dolby Laboratories FQ1 2023 Earnings Preview
Feb 01Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company
Jan 24Dolby: A 2023 Update, And Still A 'Hold'
Jan 11An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued
Jan 09Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?
Dec 25Dolby Laboratories' (NYSE:DLB) Dividend Will Be Increased To $0.27
Nov 21Dolby: Great Moat But Not Such A Great Investment Idea
Oct 29Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 38% Undervaluation?
Oct 05Dolby Laboratories Seeks Broader Growth As Macro Conditions Weigh
Sep 28At US$72.98, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Sep 20Be Wary Of Dolby Laboratories (NYSE:DLB) And Its Returns On Capital
Aug 20Dolby Laboratories goes ex-dividend tomorrow
Aug 19Dolby Laboratories Non-GAAP EPS of $0.68 beats by $0.09, revenue of $289.59M misses by $4.44M
Aug 09Dolby: Is Low-Yield Growth Worth It In This Market?
Jul 17An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 41% Undervalued
Jul 03Is It Time To Consider Buying Dolby Laboratories, Inc. (NYSE:DLB)?
Jun 17Dolby Laboratories (NYSE:DLB) Will Want To Turn Around Its Return Trends
May 18Financial Position Analysis
Short Term Liabilities: DLB's short term assets ($1.5B) exceed its short term liabilities ($394.1M).
Long Term Liabilities: DLB's short term assets ($1.5B) exceed its long term liabilities ($179.1M).
Debt to Equity History and Analysis
Debt Level: DLB is debt free.
Reducing Debt: DLB has not had any debt for past 5 years.
Debt Coverage: DLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DLB has no debt, therefore coverage of interest payments is not a concern.